Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid Leukemia

被引：1

作者：

Hoyt, Scott B. ^{[1
]}

Finocchio, Chris J. ^{[1
]}

Croll, Elizabeth ^{[1
]}

Tawa, Gregory J. ^{[1
]}

Li, Huixu ^{[2
]}

Ma, Li ^{[2
]}

Li, Kaikai ^{[2
]}

Liu, Li ^{[2
]}

Li, Ranran ^{[2
]}

Zhang, Xiaohu ^{[1
]}

Wilson, Kelli ^{[1
]}

Xu, Xin ^{[1
]}

Shah, Pranav ^{[1
]}

Williams, Jordan ^{[1
]}

Fang, Yuhong ^{[1
]}

Bolanos, Lyndsey C. ^{[3
]}

Gracia-Maldonado, Gabriel ^{[4
]}

Kolt, Amal ^{[4
]}

Robinson, Christina ^{[5
]}

Free, Jessica ^{[5
]}

Edmondson, Elijah F. ^{[5
]}

Difilippantonio, Simone ^{[5
]}

Jones, LaQuita M. ^{[6
]}

Culver-Cochran, Ashley E. ^{[3
]}

Rosenbaum, Jan S. ^{[4
]}

Starczynowski, Daniel T. ^{[3
]}

Thomas, Craig J. ^{[1
,7
]}

机构：

[1] Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA

[2] WuXi AppTec Co Ltd, Tianjin 300457, Peoples R China

[3] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA

[4] Kurome Therapeut, Cincinnati, OH 45208 USA

[5] Frederick Natl Lab Canc Res, Frederick, MD 21702 USA

[6] Cincinnati Childrens Hosp Med Ctr, Div Oncol, Cincinnati, OH 45229 USA

[7] NCI, Bethesda, MD 20814 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2024年 / 15卷 / 11期

基金：

美国国家卫生研究院;

关键词：

IRAK1; IRAK4; FLT3; kinase; AML; leukemia;

D O I：

10.1021/acsmedchemlett.4c00269

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We report the discovery of an imidazopyridine series of IRAK1/4/pan-FLT3 kinase inhibitors. Optimization of this series has produced compound 31 which displays potent and selective inhibition of IRAK1, IRAK4, FLT3, and all mutant forms of FLT3, as well as good in vitro ADME and pharmacokinetic properties. In a mouse xenograft model of AML, 31 produces survival prolongation equal to that of Gilteritinib, the leading marketed FLT3 inhibitor currently used to treat AML.

引用

页码：1843 / 1851

页数：9

共 50 条

[21] FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations
Kayser, Sabine
Levis, Mark J.
LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 243 - 255
[22] A novel and potent FLT3 and IRAK4 dual inhibitor for the treatment of acute myeloid leukemia
Yang, Rui
Wu, Lei
Zhang, Bing
Xiang, Michael
Wang, Suyue
Xiang, Camille
Lu, Zhijian
Xiang, Jason
CANCER RESEARCH, 2023, 83 (07)
[23] IL-1 Via IRAK1/4 Sustains Acute Myeloid Leukemia Stem Cells Following Treatment and Relapse
Ho, Tzu-Chieh
Kawano, Hiroki
LaMere, Mark W.
Guo, Naxin
Chiu, Yu-Chiao
Wang, Jian
Jordan, Craig T.
Dokholyan, Nikolay V.
Calvi, Laura M.
Singh, Rakesh Kumar
Becker, Michael W.
BLOOD, 2021, 138
[24] Discovery of pyridine-based derivatives as FLT3 inhibitors for the treatment of acute myeloid leukemia
Chen, Beijing
Wang, Zhongyuan
Chen, Qi
Zhang, Ying
Wu, Shengfei
Zhang, Yu
Li, Aihong
Ouyang, Weiwei
Sima, Lijie
Li, Xiaoxu
Zhao, Dongsheng
Luo, Bilan
Wang, Jianta
Tang, Lei
Su, Xiaoming
Liao, Weike
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 283
[25] Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies
Li, Zhaoyang
Younger, Kenisha
Gartenhaus, Ronald
Joseph, Ann Mary
Hu, Fang
Baer, Maria R.
Brown, Patrick
Davila, Eduardo
JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (03): : 1081 - 1097
[26] The clinical development of FLT3 inhibitors in acute myeloid leukemia
Knapper, Steven
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1377 - 1395
[27] Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia
Green, Alexa S.
Maciel, Thiago T.
Hospital, Marie-Anne
Yin, Chae
Mazed, Fetta
Townsend, Elizabeth C.
Pilorge, Sylvain
Lambert, Mireille
Paubelle, Etienne
Jacquel, Arnaud
Zylbersztejn, Florence
Decroocq, Justine
Poulain, Laury
Sujobert, Pierre
Jacque, Nathalie
Adam, Kevin
So, Jason C. C.
Kosmider, Olivier
Auberger, Patrick
Hermine, Olivier
Weinstock, David M.
Lacombe, Catherine
Mayeux, Patrick
Vanasse, Gary J.
Leung, Anskar Y.
Moura, Ivan C.
Bouscary, Didier
Tamburini, Jerome
SCIENCE ADVANCES, 2015, 1 (08):
[28] Safety of FLT3 inhibitors in patients with acute myeloid leukemia
Cerchione, Claudio
Peleteiro Raindo, Andres
Mosquera Orgueira, Adrian
Mosquera Torre, Alicia
Bao Perez, Laura
Marconi, Giovanni
Isidori, Alessandro
Perez Encinas, Manuel Mateo
Martinelli, Giovanni
EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (09) : 851 - 865
[29] Clinical use of FLT3 inhibitors in acute myeloid leukemia
Sutamtewagul, Grerk
Vigil, Carlos E.
ONCOTARGETS AND THERAPY, 2018, 11 : 7041 - 7052
[30] Recent advances in FLT3 inhibitors for acute myeloid leukemia
Tong, Lexian
Li, Xuemei
Hu, Yongzhou
Liu, Tao
FUTURE MEDICINAL CHEMISTRY, 2020, 12 (10) : 961 - 981

← 1 2 3 4 5 →